T1	Outcomes 155 174	efficacy and safety
T2	Outcomes 862 895	biopsy-confirmed acute rejections
T3	Outcomes 984 1031	incidence of steroid-sensitive acute rejections
T4	Outcomes 1088 1122	Steroid-resistant acute rejections
T5	Outcomes 1220 1225	died.
T6	Outcomes 1226 1261	Patient survival and graft survival
T7	Outcomes 1409 1436	incidence of adverse events
T8	Outcomes 1452 1483	cytomegalovirus (CMV) infection
T9	Outcomes 1537 1547	leukopenia
T10	Outcomes 1575 1580	fever
T11	Outcomes 1609 1623	herpes simplex
T12	Outcomes 1655 1671	thrombocytopenia
T13	Outcomes 1723 1737	serum sickness
T14	Outcomes 1790 1817	new onset diabetes mellitus
T15	Outcomes 1893 1908	acute rejection
T16	Outcomes 2063 2077	adverse events
T17	Outcomes 2092 2106	CMV infection.
